247 related articles for article (PubMed ID: 9097977)
1. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
2. K-ras and p53 mutations in human colorectal aberrant crypt foci.
Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
[TBL] [Abstract][Full Text] [Related]
3. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
4. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S
Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190
[TBL] [Abstract][Full Text] [Related]
5. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon.
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Gastroenterology; 1995 Feb; 108(2):434-40. PubMed ID: 7835585
[TBL] [Abstract][Full Text] [Related]
6. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous development of aberrant crypt foci in F344 rats.
Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
[TBL] [Abstract][Full Text] [Related]
11. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression?
Yamashita N; Minamoto T; Ochiai A; Onda M; Esumi H
Cancer; 1995 Mar; 75(6 Suppl):1527-33. PubMed ID: 7889486
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer.
Stopera SA; Murphy LC; Bird RP
Carcinogenesis; 1992 Nov; 13(11):2081-5. PubMed ID: 1423879
[TBL] [Abstract][Full Text] [Related]
14. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine.
Femia AP; Tarquini E; Salvadori M; Ferri S; Giannini A; Dolara P; Caderni G
Int J Cancer; 2008 Jan; 122(1):117-23. PubMed ID: 17847023
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
[TBL] [Abstract][Full Text] [Related]
16. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
18. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
Hu Y; Le Leu RK; Young GP
Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
[TBL] [Abstract][Full Text] [Related]
20. APC and K-ras gene mutation in aberrant crypt foci of human colon.
Yuan P; Sun MH; Zhang JS; Zhu XZ; Shi DR
World J Gastroenterol; 2001 Jun; 7(3):352-6. PubMed ID: 11819789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
